BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7596694)

  • 1. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia.
    Zenz W; Muntean W; Gallistl S; Zobel G; Grubbauer HM
    Pediatrics; 1995 Jul; 96(1 Pt 1):144-8. PubMed ID: 7596694
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator.
    Zenz W; Muntean W; Zobel G; Grubbauer HM; Gallistl S
    Thromb Haemost; 1995 Aug; 74(2):802-3. PubMed ID: 8585030
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Nadel S; De Munter C; Britto J; Habibi P; Levin M
    Crit Care Med; 1998 May; 26(5):971-2; author reply 972-3. PubMed ID: 9590331
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Aiuto LT; Barone SR; Cohen PS; Boxer RA
    Crit Care Med; 1997 Jun; 25(6):1079-82. PubMed ID: 9201064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Horne MD
    Crit Care Med; 1997 Jun; 25(6):909. PubMed ID: 9201041
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Zenz W; Bodó Z; Zobel G; Fanconi S; Rettenbacher A
    Crit Care Med; 1998 May; 26(5):969-71; author reply 972-3. PubMed ID: 9590330
    [No Abstract]   [Full Text] [Related]  

  • 7. Is recombinant tissue plasminogen activator an option in the treatment of meningococcus-induced purpura?
    Veldman A; Ehrenberg A; Jäger G; Ettingshausen CE; Schneider W; Kreuz W
    Crit Care Med; 2000 Feb; 28(2):598-600. PubMed ID: 10708220
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant tissue plasminogen activator in children with meningococcal purpura fulminans--role uncertain.
    Baines P; Carrol ED
    Crit Care Med; 2004 Aug; 32(8):1806-7. PubMed ID: 15286574
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolytic therapy in adult meningococcal purpura fulminans with acute renal failure and severe perfusion deficits to the extremities.
    Pechlaner C; Buratti T; Biedermann H; Joannidis M; Wiedermann CJ
    Wien Klin Wochenschr; 1999 Sep; 111(16):650-4. PubMed ID: 10510843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Peters M; Kerr S
    Crit Care Med; 1998 May; 26(5):972-3. PubMed ID: 9590332
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meningococcal purpura fulminans: treatment with recombinant protein C activator in 3 cases].
    Salinas U; Unzueta J; Vidarte MA; Rodrigo MP; Gómez JJ; Aguilera L
    Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):503-6. PubMed ID: 17993100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans.
    Bachli EB; Vavricka SR; Walter RB; Leschinger MI; Maggiorini M
    Intensive Care Med; 2003 Feb; 29(2):337. PubMed ID: 12594601
    [No Abstract]   [Full Text] [Related]  

  • 14. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
    Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
    Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during successful treatment.
    Spronk PE; Rommes JH; Schaar C; Ince C
    Thromb Haemost; 2006 Mar; 95(3):576-8. PubMed ID: 16525591
    [No Abstract]   [Full Text] [Related]  

  • 16. Plastic surgery management in pediatric meningococcal-induced purpura fulminans.
    Dinh TA; Friedman J; Higuera S
    Clin Plast Surg; 2005 Jan; 32(1):117-21, ix. PubMed ID: 15636769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thwarting a killer.
    Dixon JE; Fearneyhough PK; Callen JP
    Am J Med; 2006 Apr; 119(4):310-1. PubMed ID: 16564771
    [No Abstract]   [Full Text] [Related]  

  • 18. First manifestation of a hereditary homozygous factor VII deficiency in a 3-year-old girl suspected as purpura fulminans.
    Fischer D; Veldman A; Heller C; Kreuz W; Schneider W
    Intensive Care Med; 2003 Jan; 29(1):144. PubMed ID: 12528040
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein C concentrate and recombinant tissue plasminogen activator in meningococcal septic shock.
    Leclerc F; Cremer R; Leteurtre S; Martinot A; Fourier C
    Crit Care Med; 2000 May; 28(5):1694-7. PubMed ID: 10834762
    [No Abstract]   [Full Text] [Related]  

  • 20. Nursing care of a child with meningococcemia.
    Holland JA; Bryan S; Huff-Slankard J
    J Pediatr Nurs; 1993 Aug; 8(4):211-6. PubMed ID: 8410641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.